suck pdf from google scholar
PDF vom PMID20305008  :  Publisher
PDF vom PMID20305008
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text

  • DeepDyve
  • Pubget Overpricing

  • lüll
  • Minireview: update on incretin biology: focus on glucagon-like peptide-1
  • Brubaker PL
  • Endocrinology 2010[May]; 151 (5): 1984-9
  • The incretin hormone, glucagon-like peptide-1 (GLP-1), is now being used in the clinic to enhance insulin secretion and reduce body weight in patients with type 2 diabetes. Although much is already known about the biology of GLP-1, much remains to be understood. Hence, this review will consider recent findings related to the potential for enhancing endogenous levels of GLP-1 through selective use of secretagogues and the beneficial cardiovascular, neuroprotective, and immunomodulatory effects of GLP-1, as well as the possible effects of GLP-1 to enhance beta-cell growth and/or to induce pancreatitis or thyroid cancer. Finally, the potential for molecular medicine to enhance the success of GLP-1 therapy in the clinic is considered. A better understanding of the fundamental biology of GLP-1 may lead to new therapeutic modalities for the clinical use of this intestinal hormone.
  • |Animals[MESH]
  • |Apoptosis/drug effects[MESH]
  • |Diabetes Mellitus, Type 2/drug therapy/*metabolism[MESH]
  • |Glucagon-Like Peptide 1/*metabolism/therapeutic use[MESH]
  • |Humans[MESH]
  • |Hypoglycemic Agents/metabolism/pharmacology[MESH]
  • |Incretins/*metabolism/pharmacology[MESH]
  • |Insulin-Secreting Cells/cytology/drug effects/*metabolism[MESH]
  • |Receptors, Glucagon/agonists/metabolism[MESH]

  • *{{pmid20305008}}
    *<b>[ Minireview: update on incretin biology: focus on glucagon-like peptide-1 ]</b> Endocrinology 2010; 151(5) ; 1984-9 Brubaker PL


    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren


    1984 5.151 2010